We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New MRI Tool Introduced for Cancer Diagnosis and Therapy

By HospiMedica International staff writers
Posted on 05 Sep 2018
A superparamagnetic ferritin compound improves the accuracy of diagnosing malignant cells and provides additional opportunities for cancer treatment, claims a new study.

Researchers at Helmholtz Zentrum München (Munich, Germany), the Russian National University of Science and Technology (NUST-MISiS; Moscow, Russia), and other institutions have synthesized a novel magnetoferritin, consisting of an endogenous human protein (ferritin) and a magnetic nucleus, which has been optimized for cellular uptake and ensuing trafficking to lysosomes. More...
It can thus serve as a hypoallergenic contrast agent for optoacoustic imaging, and allow for selective photoablation of cells overexpressing the ferritin receptors.

According to the researchers, the genetically controlled uptake of the biomagnetic nanoparticles also strongly enhances third‐harmonic generation, due to the change of the refractive index caused by the magnetite–protein interface of ferritins entrapped in lysosomes. Selective uptake of magnetoferritin also enables detection of receptor‐expressing cells by magnetic resonance imaging (MRI), as well as efficient magnetic cell sorting and manipulation. A substantial increase in the blocking temperature of lysosomally entrapped magnetoferritin was also observed, which could allow for specific ablation of genetically defined cell populations by magnetic hyperthermia. The study was published in the May 2018 issue of Advanced Functional Materials.

“Spreading with the blood flow, magnetoferritin will be captured by the targeted tumor cells; as has been shown in a large number of studies, these cells actively capture transferrin, the protein responsible for the transport of iron in the blood,” said study co-author Professor Ulf Wiedwald, PhD, of the NUST-MISiS biomedical nanomaterials laboratory. “The receptors are capable of capturing the magnetoferritin as well. Once they get into the lysosomes of targeted cells, the magnetoferritin will further enhance the contrast signal.”

Transferrins are iron-binding blood plasma glycoproteins that control the level of free iron in biological fluids. Although the iron bound to transferrin is less than 0.1% of total body iron, it forms the most vital iron pool with the highest rate of turnover (25 mg/d). Transferrin also plays a key role in areas where erythropoiesis and active cell division occur, delivering iron absorption centers in the duodenum and white blood cell macrophages to all tissues.

Related Links:
Helmholtz Zentrum München
Russian National University of Science and Technology


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.